Clinical Research Organisations (CROs) are under constant pressure to deliver efficient, successful trials for their clients. With increasing demands for precision, regulatory compliance, and cost-effectiveness, CROs need more than just traditional trial strategies—they need data-driven, AI-powered insights. TrialKey, a leading innovator in clinical trial optimisation, offers CROs a unique partnership that leverages advanced AI to streamline trial design, boost patient recruitment, and ensure higher success rates.
Why Partner with TrialKey?
TrialKey’s AI-powered platform, built on a robust dataset of over 450,000 clinical trials, is specifically designed to assist CROs in optimising every stage of the trial process. By collaborating with TrialKey, CROs gain access to powerful tools that go beyond standard trial data to offer comprehensive, customised reports and recommendations tailored to each trial’s unique needs.
Key Benefits for CROs:
- Enhanced Trial Design: With AI-driven insights, CROs can tailor study designs with pinpoint accuracy, ensuring protocols are aligned with proven success factors.
- Optimised Patient Recruitment: TrialKey’s platform provides data-backed recommendations for inclusion and exclusion criteria, helping CROs streamline recruitment and boost retention.
- Reduced Risk: By identifying potential risks, from dropout rates to adverse events, TrialKey empowers CROs to address issues proactively and minimise trial disruptions.
TrialKey’s AI Capabilities for CRO Success
TrialKey’s platform is grounded in over 1,300 variables spanning protocol specifics, patient demographics, and trial execution details. Each trial is simulated up to 100,000 times to deliver reliable predictions and success rates, enabling CROs to present evidence-backed strategies to their clients with confidence.
Key Features for CROs:
- Probability of Success Score: TrialKey calculates the likelihood of a trial meeting its primary endpoints, providing CROs with a success percentage that’s supported by extensive data and AI modelling.
- Competitor Benchmarking: CROs receive comparative insights showing where their trial stands against similar studies in the industry, highlighting competitive strengths.
- Site and Recruitment Optimisation: TrialKey recommends ideal trial locations and recruitment strategies tailored to the therapeutic area and patient profile, ensuring efficient resource allocation.
- Inclusion/Exclusion Criteria Refinement: By refining criteria, CROs can maximise recruitment potential and improve statistical power, aligning the trial design with optimal patient characteristics.
How TrialKey Supports CROs from Proposal to Project Success
TrialKey’s partnership framework for CROs is structured to provide continuous support from the initial proposal stage to project completion. Here’s how the process works:
- Initial Consultation: TrialKey’s team collaborates with the CRO to understand the project’s scope and review key contacts and objectives.
- Custom Report Creation: After the CRO wins the project, TrialKey generates a client-branded, preliminary report, covering critical insights like success probability, competitor benchmarking, technologies used by competitors, and risk factors.
- Full Report and Client Presentation: For ongoing projects, TrialKey delivers a comprehensive report, detailing protocol recommendations, recruitment strategies, and endpoint analyses. The TrialKey team can also join client meetings to present the data-backed findings directly to the sponsor.
- Post-Launch Engagement: TrialKey provides ongoing support, updating data as trials progress and refining recommendations to ensure trial success.
Streamlined Onboarding for CRO Partners
TrialKey’s onboarding process is designed to seamlessly integrate its platform into the CRO’s workflow. After contract finalisation, TrialKey supports CROs with marketing assets, digital launch announcements, and continuous engagement. This collaborative approach ensures that CROs can leverage TrialKey’s capabilities effectively and communicate the partnership’s value to their clients.
Onboarding Steps:
- Week 1: Contract signing, ASX announcement preparation, and an introductory call to discuss partnership scope.
- Week 2: Development of marketing assets, such as branded content and social media tiles, to communicate the partnership.
- Week 3 and Ongoing: Launch of digital announcements, public relations outreach, and regular updates to demo presentations and marketing collateral.
TrialKey’s Data-Driven Reports: Adding Value for CRO Clients
TrialKey provides CROs with two key report types to support trial success:
- Preliminary Client Branded Report: A concise overview covering probability scores, competitor benchmarks, tree map graph of technologies used in trials for that condition, and a visual probability density graph—ideal for proposals to sponsors.
- Full Detailed Report: This comprehensive document includes in-depth analysis of success likelihood, site and patient recruitment recommendations, inclusion/exclusion criteria, endpoint optimisation, risk mitigation strategies, and detailed visualisations.
By presenting clear, data-driven insights, CROs can offer clients a scientifically validated approach to trial design that’s optimised for success.
Why Choose TrialKey as a CRO Partner?
TrialKey combines AI expertise with extensive real-world trial data to offer a partnership that elevates CRO capabilities. With TrialKey’s support, CROs can reduce trial costs, accelerate timelines, and ensure higher trial success rates. Together, TrialKey and CROs can make a meaningful impact on clinical research, enabling more effective treatments to reach patients faster and with greater confidence.
For CROs looking to set themselves apart in a competitive market, partnering with TrialKey provides a strategic advantage, backed by data-driven insights and AI-powered validation.
